DE3581337D1 - Peptide. - Google Patents

Peptide.

Info

Publication number
DE3581337D1
DE3581337D1 DE8585306085T DE3581337T DE3581337D1 DE 3581337 D1 DE3581337 D1 DE 3581337D1 DE 8585306085 T DE8585306085 T DE 8585306085T DE 3581337 T DE3581337 T DE 3581337T DE 3581337 D1 DE3581337 D1 DE 3581337D1
Authority
DE
Germany
Prior art keywords
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585306085T
Other languages
English (en)
Inventor
Shumpei Sakakibara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE3581337D1 publication Critical patent/DE3581337D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C07K14/582—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8585306085T 1984-08-29 1985-08-28 Peptide. Expired - Lifetime DE3581337D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59180000A JPH0672157B2 (ja) 1984-08-29 1984-08-29 新規ペプチド

Publications (1)

Publication Number Publication Date
DE3581337D1 true DE3581337D1 (en) 1991-02-21

Family

ID=16075699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585306085T Expired - Lifetime DE3581337D1 (en) 1984-08-29 1985-08-28 Peptide.

Country Status (3)

Country Link
EP (1) EP0173557B1 (de)
JP (1) JPH0672157B2 (de)
DE (1) DE3581337D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042782B2 (ja) * 1985-11-05 2000-05-22 サイオス インコーポレイテッド 心房性ナトリウム尿排泄亢進ペプチド類似化合物
US4716147A (en) * 1986-03-27 1987-12-29 Monsanto Company Synthetic airial peptides
CA1339678C (en) * 1986-09-29 1998-02-17 Takeda Chemical Industries Ltd. Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease
US5565606A (en) * 1986-10-21 1996-10-15 Hoechst Aktiengesellschaft Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DE3723551A1 (de) * 1987-07-16 1989-01-26 Hoechst Ag Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
JPS63112598A (ja) * 1986-10-27 1988-05-17 Shionogi & Co Ltd 新規な降圧利尿性ペプチド
JPS63225399A (ja) * 1986-10-28 1988-09-20 Takeda Chem Ind Ltd ペプチド誘導体およびその製造法
DK531986D0 (da) * 1986-11-07 1986-11-07 Novo Industri As Peptider
US5095004A (en) * 1987-03-25 1992-03-10 Bio-Mega Inc. Fluorine containing atrial natriuretic peptides
EP0292256A3 (de) * 1987-05-19 1990-10-03 Merck & Co. Inc. Peptide mit ANF-Wirksamkeit
CA1337891C (en) * 1987-12-16 1996-01-02 John Dimaio Anf derivatives with novel bridging
DK380288D0 (da) * 1988-07-07 1988-07-07 Novo Industri As Hidtil ukendet peptider
JP2809533B2 (ja) * 1991-01-31 1998-10-08 壽之 松尾 Ｃｎｐ類似体ペプチド
US5767239A (en) * 1994-06-02 1998-06-16 Boehringer Mannheim Gmbh Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
ZA846084B (en) * 1983-08-29 1985-05-29 Montreal Inst Rech Cliniques Natriuretic factors
US4496544A (en) * 1983-11-10 1985-01-29 Washington University Atrial Peptides
JPS60136596A (ja) * 1983-12-26 1985-07-20 Suntory Ltd ペプチド及びこれを有効成分とする利尿剤
US4952561A (en) * 1984-02-07 1990-08-28 Merck & Co., Inc. Cardiac atrial peptides
JPS60184098A (ja) * 1984-03-02 1985-09-19 Suntory Ltd 新規なペプチド及びこれを有効成分とする利尿剤
WO1985004870A1 (en) * 1984-04-19 1985-11-07 Biotechnology Research Partners, Ltd. Novel atrial natriuretic/vasodilator polypeptides
AU4292785A (en) * 1984-04-24 1985-11-15 Salk Institute For Biological Studies, The Atrial peptide analogs
CA1340625C (en) * 1984-06-29 1999-07-06 Peter L. Davies Cloned cardionatrin cdna

Also Published As

Publication number Publication date
JPH0672157B2 (ja) 1994-09-14
JPS6157599A (ja) 1986-03-24
EP0173557A3 (en) 1987-07-15
EP0173557B1 (de) 1991-01-16
EP0173557A2 (de) 1986-03-05

Similar Documents

Publication Publication Date Title
DE3576280D1 (en) Ultraschall-hyperthermieapparat.
DE3578762D1 (en) Haemodiafiltrationsgeraet.
DE3586242D1 (en) Steroid-liposome.
DE3587315D1 (en) Automatisierter polypeptidsyntheseapparat.
DE3580444D1 (en) Benzoylphenylharnstoffe.
DE3576279D1 (en) Thermoplastisches polyurethanprodukt.
DE3577477D1 (en) Thermistorthermometer.
DE3583078D1 (en) Fluidmaschine.
DE3582243D1 (en) Rohrabschneider.
DE3581951D1 (en) Lsi-microcomputer.
DE3578734D1 (en) Differentialsensor.
DE3587525D1 (en) Stepmotor.
DE3587460D1 (en) Arylhydroxamsaeuren.
DE3577993D1 (en) Phenazinfarbstoffe.
DE3584299D1 (en) Duennfilmmagnetkoepfe.
DE3580294D1 (en) Ruehrsysteme.
DE3582853D1 (en) Duennfilmmagnetkopf.
DE3587295D1 (en) Tomographisches testgeraet.
DE3579794D1 (en) Arbiterschaltung.
DE3581337D1 (en) Peptide.
DE3584508D1 (en) Vinyldispersionsharz.
DE3576402D1 (en) Waegeapparat.
DE3587235D1 (en) Tricyclische thiazolderivate.
DE3582057D1 (en) Amidinverbindungen.
DE3585976D1 (en) Disaccharidderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee